Revenue Performance - Q4 2025 reported revenue was $159 million, up 6% year over year, with organic revenue growth of 4%[2] - FY 2025 revenue totaled $594 million, representing a 4% increase year over year, with organic revenue growth of 3%[9] - Multiomics revenue for Q4 2025 was $73 million, an 11% increase year over year, with organic growth of 10%[9] - Sample Management Solutions revenue for FY 2025 was $325 million, up 2% year over year, with organic revenue growth of 1%[9] - Total revenue for the three months ended September 30, 2025, was $159,192 thousand, an increase of 5.3% compared to $150,604 thousand for the same period in 2024[23] - Total revenue for the year ended September 30, 2025, reached $325 million, a 2% increase from $319 million in 2024[48] - The company experienced a currency exchange rate impact of -1% on total revenue for the year ended September 30, 2025[48] Profitability Metrics - Adjusted EBITDA for FY 2025 was $66 million, with an adjusted EBITDA margin of 11.2%, an improvement of 310 basis points year over year[16] - Operating income for Q4 2025 was $2 million, with an operating margin of 1.2%, an improvement of 430 basis points year over year[9] - Adjusted operating income for Q4 2025 was $9 million, with an adjusted operating margin of 5.7%, an improvement of 60 basis points year over year[9] - GAAP operating income for the quarter ended September 30, 2025, was $8,015,000, compared to $7,503,000 for the same period in 2024, representing an increase of 6.8%[44] - Non-GAAP adjusted operating income for the year ended September 30, 2025, was $27,550,000, significantly higher than $11,106,000 in 2024, indicating a growth of 147.5%[44] Net Income and Earnings Per Share - Diluted EPS from continuing operations for Q4 2025 was $1.11, compared to a loss of $0.04 in the prior year[9] - Net income for the three months ended September 30, 2025, was $47,137 thousand, a significant recovery from a net loss of $6,639 thousand in the prior year[23] - Basic net income per share for the three months ended September 30, 2025, was $1.03, compared to a loss of $0.14 per share in the same period of 2024[23] - Net income from continuing operations for Q4 2025 was $50,853, compared to a loss of $331 in Q3 2025 and a loss of $1,745 in Q4 2024[30] - For the year ended September 30, 2025, net income from continuing operations was $23,658, a significant improvement from a loss of $24,366 in the previous year[31] Cash and Balance Sheet - The company ended FY 2025 with a total balance of cash and marketable securities of $546 million[16] - Cash and cash equivalents at the end of the period were $279,783 thousand, slightly down from $280,030 thousand a year earlier[25] - Total assets decreased to $2,056,854 thousand as of September 30, 2025, from $2,100,265 thousand in 2024[25] - Total liabilities remained relatively stable at $333,608 thousand compared to $332,418 thousand in the previous year[25] - The company reported a net cash provided by operating activities of $72,181 thousand for the year ended September 30, 2025, compared to $49,743 thousand in 2024[28] Transformation and Costs - The company is focused on long-term benefits through transformation costs aimed at cost reduction and productivity improvement, which are part of the 2024 cost reduction plan[41] - Transformation costs for Q4 2025 amounted to $634, down from $1,542 in Q3 2025 and $4,568 in Q4 2024[30] - Transformation costs for the year ended September 30, 2025, amounted to $2,820,000, up from $395,000 in 2024, reflecting increased investment in strategic projects[46] - The company incurred merger and acquisition costs of $87 in Q4 2025, compared to $58 in Q3 2025 and $52 in Q4 2024[30] Gross Profit and Margins - Gross profit for the year ended September 30, 2025, was $270,280 thousand, up from $254,622 thousand in 2024, reflecting a gross margin improvement[23] - GAAP gross profit for the quarter ended September 30, 2025, was $72,274 thousand, representing a 45.4% margin, compared to $66,404 thousand (46.2%) in the previous quarter and $68,487 thousand (45.5%) in the same quarter last year[40] - Non-GAAP adjusted gross profit for the same quarter was $74,362 thousand, or 46.7%, up from $68,497 thousand (47.6%) in the previous quarter and $70,728 thousand (47.0%) year-over-year[40] - For the year ended September 30, 2025, GAAP gross profit totaled $270,280 thousand, with a margin of 45.5%, compared to $254,622 thousand (44.4%) for the previous year[42] - Non-GAAP adjusted gross profit for the year was $278,315 thousand, or 46.9%, compared to $263,045 thousand (45.9%) in the prior year[42]
Azenta(AZTA) - 2025 Q4 - Annual Results